Rush University Medical Center is recruiting participants for a nationwide trial of a COVID-19 vaccine developed by the University of Oxford in England and AstraZeneca, a multinational pharmaceutical company.
The COVID Research Program is rapidly enrolling patients from New Jersey, which has one of the world’s highest concentrations of COVID-19 patients. Atlantic Health System offers a study sponsored by TScan Therapeutics, Inc., a leading T cell therapeutics company in Waltham, Massachusetts, focused on identifying the precise way the human immune system recognizes and responds to infections like COVID-19 or other diseases, like cancers. TScan has developed a novel technology that enables them to identify the natural targets of T cells.
ILSI hosts a free public webinar on COVID-19, nutrition and immune response.